Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G32254QI
Summary
- GlyTouCan ID
-
G32254QI
- IUPAC Condensed
- Neu5Ac(a2-3)Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-
- Motifs
- GL-7 globoseries ganglioside SSEA-4
- Subsumption Level
- Fully-defined saccharide
- Monoisotopic Mass
- 1160.4
3D Structures
GlycoShape
Organisms
| Organisms | Evidence |
|---|---|
| Gallus gallus (chicken) | |
| Mus musculus (house mouse) | |
| Homo sapiens (human) |
Taxonomic Hierarchy
KEGG BRITE Database
G50116PC
G99053DY
GlycoEpitope
- Epitope ID
- EP0099
Sequence Descriptors
- GlycoCT
-
RES 1b:b-dglc-HEX-1:5 2b:b-dgal-HEX-1:5 3b:a-dgal-HEX-1:5 4b:b-dgal-HEX-1:5 5s:n-acetyl 6b:b-dgal-HEX-1:5 7b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 8s:n-acetyl LIN 1:1o(4+1)2d 2:2o(4+1)3d 3:3o(3+1)4d 4:4d(2+1)5n 5:4o(3+1)6d 6:6o(3+2)7d 7:7d(5+1)8n
- WURCS
- WURCS=2.0/5,6,5/[a2122h-1b_1-5][a2112h-1b_1-5][a2112h-1a_1-5][a2112h-1b_1-5_2*NCC/3=O][Aad21122h-2a_2-6_5*NCC/3=O]/1-2-3-4-2-5/a4-b1_b4-c1_c3-d1_d3-e1_e3-f2
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 31831622 | The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibody | Soliman C | 2019 Dec 12 |
|
| 18773292 | Complex N-glycans or core 1-derived O-glycans are not required for the expression of stage-specific antigens SSEA-1, SSEA-3, SSEA-4, or Le(Y) in the preimplantation mouse embryo | Williams SA | 2008 Sep 05 |
|
| 7509790 | Common tetrasaccharide epitope NeuAc alpha 2-->3Gal beta 1-->3(Neu-Ac alpha 2-->6)GalNAc, presented by different carrier glycosylceramides or O-linked peptides, is recognized by different antibodies and ligands having distinct specificities | Saito S | 1994 Feb 25 |
|
